World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. AnaptysBio Inc.

    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Net Income in USD
    -57 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
    Company Website
    ANAPTYSBIO INC

  2. Marinus Pharmaceuticals

    World Rank (Jan-05-2024)
    11,762
    Market Cap (Jan-05-2024)
    0.574 Billion USD
    World Rank (Jul-30-2023)
    12,607
    Market Cap (Jul-30-2023)
    0.512 Billion USD
    World Rank (Dec-25-2022)
    18,773
    Market Cap (Dec-25-2022)
    0.174 Billion USD
    World Rank (Jan-07-2022)
    14,722
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    25 Million USD
    Annual Operating Income in USD
    -112 Million USD
    Annual Net Income in USD
    -20 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Marinus Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an investigational drug, ganaxolone which is an innovative and much needed potential treatment option for children and adults. The company annual revenue is 1.72 million USD and 82 employees as on 2020. The headquarters is in USA.
    Company Website
    MARINUS PHARMACEUTICALS

  3. Prestige Biopharma Limited

    World Rank (Jan-05-2024)
    11,796
    World Rank (Jul-30-2023)
    11,796
    Market Cap (Jul-30-2023)
    0.582 Billion USD
    World Rank (Dec-25-2022)
    14,572
    Market Cap (Dec-25-2022)
    0.360 Billion USD
    World Rank (Jan-07-2022)
    18,935
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Headquarters Country
    South Korea
    Company Website
    PRESTIGE BIOPHARMA LIMITED

  4. Allogene Therapeutics

    World Rank (Jan-05-2024)
    11,801
    Market Cap (Jan-05-2024)
    0.570 Billion USD
    World Rank (Jul-30-2023)
    10,537
    Market Cap (Jul-30-2023)
    0.718 Billion USD
    World Rank (Dec-25-2022)
    9,189
    Market Cap (Dec-25-2022)
    0.859 Billion USD
    World Rank (Jan-07-2022)
    6,446
    Market Cap (Jan-07-2022)
    1.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -335 Million USD
    Annual Net Income in USD
    -332 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Allogene Therapeutics is a Clinical Stage Biotechnology company. It single minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell therapies for cancer and researchers is dedicated to discovery and translational research, development and cell manufacturing. The headquarters is in USA.
    Company Website
    ALLOGENE THERAPEUTICS

  5. Northwest Biotherapeutics Inc.

    World Rank (Jan-05-2024)
    11,833
    World Rank (Jul-30-2023)
    11,833
    Market Cap (Jul-30-2023)
    0.578 Billion USD
    World Rank (Dec-25-2022)
    9,219
    Market Cap (Dec-25-2022)
    0.854 Billion USD
    World Rank (Jan-07-2022)
    11,641
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -67 Million USD
    Annual Net Income in USD
    -105 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Northwest Biotherapeutics, Inc is a Clinical Stage Biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. The company annual revenue is 1.29 million USD and 17 employees as on 2020. The headquarters is in USA.
    Company Website
    NORTHWEST BIOTHERAPEUTICS, INC.

  6. Aerovate Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,835
    Market Cap (Jan-05-2024)
    0.568 Billion USD
    World Rank (Jul-30-2023)
    12,989
    Market Cap (Jul-30-2023)
    0.481 Billion USD
    World Rank (Dec-25-2022)
    10,461
    Market Cap (Dec-25-2022)
    0.687 Billion USD
    World Rank (Jan-07-2022)
    17,917
    Market Cap (Jan-07-2022)
    0.24 Billion USD
    Headquarters Country
    USA
    Company Website
    AEROVATE THERAPEUTICS, INC.

  7. Ocumension Therapeutics

    World Rank (Jan-05-2024)
    11,883
    Market Cap (Jan-05-2024)
    0.564 Billion USD
    World Rank (Jul-30-2023)
    9,453
    Market Cap (Jul-30-2023)
    0.870 Billion USD
    World Rank (Dec-25-2022)
    9,220
    Market Cap (Dec-25-2022)
    0.854 Billion USD
    World Rank (Jan-07-2022)
    7,656
    Market Cap (Jan-07-2022)
    1.42 Billion USD
    Headquarters Country
    China
    Company Website
    OCUMENSION THERAPEUTICS

  8. Biospecifics Technologies

    World Rank (Jan-05-2024)
    11,969
    World Rank (Jul-30-2023)
    11,969
    World Rank (Dec-25-2022)
    11,969
    World Rank (Jan-07-2022)
    11,969
    Headquarters Country
    USA
    Company Profile
    Endo Pharmaceuticals acquired BioSpecifics in Dec 2020 for 658 Million USD.

  10. Frontage Holdings Corporation

    World Rank (Jan-05-2024)
    12,020
    Market Cap (Jan-05-2024)
    0.551 Billion USD
    World Rank (Jul-30-2023)
    11,442
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    10,329
    Market Cap (Dec-25-2022)
    0.703 Billion USD
    World Rank (Jan-07-2022)
    9,583
    Market Cap (Jan-07-2022)
    0.97 Billion USD
    Annual Revenue in USD
    250 Million USD
    Annual Operating Income in USD
    37 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Frontage Holdings Corporation is Biotechnology and Healthcare company with the drug discovery and development. The company annual revenue is 125.8 million USD as on 2020. The headquarters is in USA.
    Company Website
    FRONTAGE HOLDINGS CORPORATION

Share